ArticleBlood advances2019

Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.

Jingrui Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.